Search results
Results from the WOW.Com Content Network
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee. Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company.
Accredo Health Group, Inc. is a specialty pharmaceutical and service provider for patients with complex and chronic health conditions. [1] Accredo provides specialty drugs, drugs that cost more than $600 per month, with the average being $10,000 a month, which treat serious conditions such as multiple sclerosis, rheumatoid arthritis, hemophilia and cancer. [1]
The top ten specialty pharmacies in 2014 were CVS Specialty parent company CVS Health with $20.5B in sales, Express Scripts's Accredo at $15B, Walgreens Boots Alliance's Walgreens Specialty at $8.5B, UnitedHealth Group's OptumRx at $2.4B, Diplomat Pharmacy at $2.1B, Catamaran's BriovaRx at $2.0B, Specialty Prime Therapeutics's Prime ...
[independent source needed] As of 2013, its health care providers saw more than 1.6 million patients each year and its hospitals perform more than 35,000 surgical procedures and see 65,000 patients in its Emergency Room. The Medical Center employed 19,600 staff.
Bloomberg News reported in January that Walgreens was exploring a sale of the unit. Walgreens bought the remaining stake in Shields for $1.37 billion in 2022, after spending $970 million to ...
Middleton is a city in Hardeman County, Tennessee, United States. The population was 706 at the 2010 census , [ 5 ] up from 602 at the 2000 census. It is located at the intersection of Tennessee State Route 125 and Tennessee State Route 57 .
Medco provided pharmacy services to private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D Prescription Drug Plans. Medco was a member of the S&P 500 and ranked number 34 on the 2011 Fortune 500 list, [1] with 2011 revenues of more than $70 billion. [2]